News

RESEARCH TRIANGLE PARK, NC (RTP) – December 11, 2017 – Dignify Therapeutics, LLC, a leading developer of therapies for bladder and bowel dysfunction, announced the appointment of Nadia Rupniak, PhD, as Executive Vice President of Drug Development. Dr. Rupniak is an internationally recognized neuroscientist and drug developer, with experience in efficacy and safety pharmacology, toxicology,…

RESEARCH TRIANGLE PARK, NC (September 19, 2017) – Dignify Therapeutics LLC, a drug development company focused on restoring bladder and bowel control for the elderly, as well as people with spinal injury, multiple sclerosis, or diabetes, received three NIH SBIR/STTR grants in 2017 totaling $4.1 million. The grants were awarded by the National Institute of…

RESEARCH TRIANGLE PARK, NC (RTP) – March 22, 2017 – Dignify Therapeutics, LLC, a leading developer of therapies for bladder and bowel dysfunction, announced that Michael Camilleri, M.D. has joined Dignify’s scientific advisory board.  Dr. Camilleri is currently Professor of Medicine and Physiology at the Mayo Clinic School of Medicine in Rochester, Minn. and also…

RESEARCH TRIANGLE PARK, NC (RTP) – October 11, 2016 – Dignify Therapeutics LLC, a drug development company focused on restoring bladder and bowel control to people with spinal injury, spina bifida, and other neurological conditions, received three NIH SBIR/STTR grants in the third quarter totaling $3.1 million.  The grants were awarded by the National Institute of…

RESEARCH TRIANGLE PARK, NC (RTP) – February 4, 2015 – Dignify Therapeutics LLC, a drug development company focused on restoring bladder and bowel control to people with spinal injury, spina bifida, and other neurological conditions, today announced the completion of a $3.15 million equity financing. RA Capital Management, Eshelman Ventures LLC and Terry Engel, an…

RESEARCH TRIANGLE PARK, NC (RTP) – February 3, 2015 – Dignify Therapeutics, LLC, announced that Michael Jay, PhD, and Kristy Borawski, MD, have joined Dignify’s scientific advisory board. Dr. Jay is the Fred Eshelman Distinguished Professor of Molecular Pharmaceutics, and Division Chair at the Eshelman School of Pharmacy at University of North Carolina, Chapel Hill….

RESEARCH TRIANGLE PARK, NC–(January 5, 2015) – Dignify Therapeutics LLC, a drug development company focused on restoring bladder and bowel control to people with spinal injury, spina bifida, and other neurological conditions, has received a $250,000 Small Business Research Loan (SRL) from the North Carolina Biotechnology Center.  The loan supports preclinical development of Dignify’s lead…

RESEARCH TRIANGLE PARK, NC (RTP) – November 4, 2014 – Dignify Therapeutics LLC, a drug development company focused on restoring bladder and bowel control to people with spinal injury, spina bifida, and other neurological conditions, has received a $50,000 grant from the North Carolina Office of Science, Technology & Innovation’s One North Carolina Small Business…

RESEARCH TRIANGLE PARK, NC (RTP) – August 15, 2014 – Dignify Therapeutics LLC, a drug development company focused on restoring bladder and bowel control to people with spinal injury, spina bifida, and other neurological conditions, has been awarded a Phase 1 Small Business Innovation Research (SBIR) grant in the amount of $159,000 from the Eunice…